Safety and efficacy of rimegepant orally disintegrating tablet for the acute treatment of migraine in China and South Korea: a phase 3, double-blind, randomised, placebo-controlled trial

Shengyuan Yu, Byung‐Kun Kim, Aihong Guo, Manho Kim, Mingjie Zhang, Zhen Wang, Jianguang Liu, Heui‐Soo Moon, Ge Tan, Qian Yang, Donnie McGrath, Michael Hanna, David Stock, Gao Yanfei, Robert Croop, Zhihong Lu